Internetové knihkupectví s veterinární tématikou
This guide addresses the two-way interaction between the heart and kidney (cardiovascular–renal axis) and shows how both acute and chronic disorders of either of these organs can affect the function of the other. To achieve its objective, the book describes the pathophysiology, diagnostic approaches, and clinical management of these disorders.
Autor: Javier Duque,Rafael Barrera
Nakladatel | Servet |
---|---|
ISBN | 9788418020551 |
Vydání | 2020 |
Vazba | pevná |
Počet stran | 136 |
1. Cardiorenal syndrome in human medicine | 1 |
Introduction | 2 |
Types of cardiorenal syndrome | 2 |
Cardiorenal syndrome type 1 (CRS1) | 2 |
Definition and epidemiology of CRS1 | 2 |
Pathophysiology of CRS1 | 3 |
Diagnosis of CRS1 | 3 |
Treatment of CRS1 | 4 |
Cardiorenal syndrome type 2 (CRS2) | 6 |
Definition and epidemiology of CRS2 | 6 |
Pathophysiology of CRS2 | 7 |
Diagnosis of CRS2 | 7 |
Treatment of CRS2 | 7 |
Cardiorenal syndrome type 3 (CRS3) | 8 |
Definition and epidemiology of CRS3 | 8 |
Pathophysiology of CRS3 | 8 |
Diagnosis of CRS3 | 8 |
Treatment of CRS3 | 9 |
Cardiorenal syndrome type 4 (CRS4) | 9 |
Definition and epidemiology of CRS4 | 9 |
Pathophysiology of CRS4 | 10 |
Treatment of CRS4 | 10 |
Cardiorenal syndrome type 5 (CRS5) | 10 |
Definition and epidemiology of CRS5 | 10 |
Pathophysiology of CRS5 | 11 |
Diagnosis of CRS5 | 11 |
Treatment of CRS5 | 11 |
2. Overview of the cardiovascular-renal axis in dogs and cats | 13 |
Introduction | 14 |
Pathophysiology | 15 |
Classification | 17 |
Cardiovascular-renal disorders secondary to acute heart disease (CVRD,) | 18 |
Pathophysiology | 18 |
Diagnostic tests | 20 |
Treatment | 20 |
Cardiovascular-renal disorders secondary to chronic heart disease (CVRD) | 21 |
Pathophysiology | 21 |
Diagnostic tests | 24 |
Treatment | 25 |
Cardiovascular-renal disorders secondary to acute renal diseases (CVRD) | 26 |
Pathophysiology | 26 |
Diagnostic tests | 27 |
Treatment | 28 |
Cardiovascular-renal disorders secondary to chronic kidney disease (CVRD) | 30 |
Pathophysiology | 30 |
Diagnostic tests | 31 |
Treatment | 32 |
Cardiovascular-renal disorders secondary to concomitant cardiac and renal diseases (CVRD) | 32 |
Pathophysiology | 32 |
Diagnostic tests | 34 |
Treatment | 34 |
Acute cardiovascular disorders causing acute kidney injury | 35 |
Introduction | 36 |
Aetiology | 36 |
Pathophysiology | 36 |
Pathophysiology of acute heart failure | 37 |
Haemodynamic response | 38 |
Worsening renal function | 41 |
Haemodynamic mechanisms | 42 |
Neurohormonal mechanisms | 42 |
Inflammatory mechanisms | 42 |
Intrinsic tubular lesions | 42 |
Diagnosis | 43 |
Urea and creatinine | 43 |
New markers | 43 |
Clinical management | 44 |
Chronic cardiovascular disorders leading to chronic kidney disease | 45 |
Introduction | 45 |
Aetiology | 45 |
Mitral valve degeneration | 45 |
Dilated cardiomyopathy | 46 |
Hypertrophic cardiomyopathy in cats | 46 |
Pathophysiology | 47 |
Diagnosis | 49 |
Diagnostic imaging | 49 |
Radiology | 49 |
Ultrasound | 50 |
Blood pressure measurement | 50 |
Laboratory tests | 51 |
Kidney disease biomarkers | 51 |
Cardiac disease biomarkers | 54 |
Haematology | 54 |
Clinical management | 54 |
4. Cardiovascular disorders secondary to kidney disease | 57 |
Acute kidney disease contributing to impaired cardiac function | 58 |
Introduction | 58 |
Aetiology | 59 |
Pathophysiology | 59 |
Direct effects of AKI on the heart | 59 |
Immune system impairment | 59 |
Inflammation and oxidative stress | 59 |
Apoptosis | 59 |
Neurohormonal activation | 59 |
Indirect effects of AKI on the heart | 61 |
Fluid overload | 61 |
Electrolyte imbalances | 61 |
Acidosis | 62 |
Uraemic toxins | 62 |
Diagnosis | 63 |
Diagnostic imaging | 63 |
Radiology | 63 |
Ultrasound | 63 |
Laboratory diagnosis | 64 |
Clinical management | 64 |
By stage | 64 |
High risk of acute kidney injury | 64 |
Stage 1 | 65 |
Stage 2 (injury) | 65 |
Stage 3 (renal failure) | 65 |
Conservative treatment | 65 |
Fluid therapy | 65 |
Hyperkalaemia | 67 |
Hypokalemia | 68 |
Acidosis | 68 |
Hypercalcaemia | 69 |
Hypocalcaemia | 69 |
Hyperphosphataemia | 69 |
Recovery of diuresis | 69 |
Management of respiratory problems | 70 Management of hypertension |
Management of gastrointestinal signs | 70 ¨ |
Renal replacement therapy | 70 |
Chronic kidney disease contributing to impaired cardiac function | 71 |
Introduction | 71 |
Aetiology | 73 |
Pathophysiology | 74 |
Systemic hypertension | 74 |
Uraemia | 74 |
Electrolyte abnormalities | 75 |
Plasma volume abnormalities | 75 |
Drug toxicity | 75 |
Anaemia | 76 |
Canine leishmaniasis | 76 |
Diagnosis | 77 |
Blood pressure measurement | 77 |
Electrocardiography | 78 |
Diagnostic imaging | 78 |
Laboratory tests | 78 |
Clinical management | 80 |
5. Cardiovascular-renal disorders secondary to systemic diseases and concomitant cardiorenal diseases | 81 |
Introduction | 82 |
Diagnosis | 82 |
Assessment of heart damage | 82 |
Assessment of kidney damage | 89 |
Critical patients: sepsis, SIRS, shock, and infectious diseases | 90 |
Endocrine diseases | 91 |
Diabetes mellitus | 91 |
Hyperthyroidism | 92 |
Hypothyroidism | 92 |
6. Anaesthetic management of patients with cardiovascular-renal axis disorders | 93 |
Introduction | 94 |
Patients with cardiovascular disease affecting the renal system | 95 |
Acute cardiovascular disorders | 96 |
Chronic cardiovascular disorders | 100 |
Dilated cardiomyopathy and valvular insufficiency | 100 |
Hypertrophic cardiomyopathy and valvular stenosis | 102 |
Patients with renal disease affecting the cardiovascular system | 104 |
Anaesthesia in patients with acute Kidney injury | 106 |
Anaesthesia in patients with chronic Kidney injury | 107 |
References | 109 |